Global Abdominal Surgical Robots Market: Drivers
The global abdominal surgical robots market is expected to experience significant growth over the forecast period due to increasing approval of robotic and surgical navigation systems by the U.S. Food and Drug Administration (FDA) to perform complex spinal surgeries. For instance, in March 2019, the U.S. Food and Drug Administration (FDA) approved ROSA ONE Spine System of Zimmer Biomet. ROSA ONE Spine System is used as robotics as well as navigation technology solution and helps to perform complex spine procedures.
Furthermore, in March 2018, the U.S. Food and Drug Administration (FDA) provided approval to Auris Health, Inc for its Monarch Platform, which is a flexible robotic endoscopic platform used for the treatment of lung cancer.
Moreover, in April 2017, Intuitive Surgical received CE Mark approval in Europe for its Da Vinci X Surgical System, which provides surgeons an advanced set of instruments to perform robotic-assisted minimally invasive surgery at lower cost. Therefore, increasing number of approval of robotic and surgical robotic, and surgical navigation system by various companies is expected to boost the global abdominal surgical robots market growth.
The increasing investment for abdominal robotic surgery by companies is also boosting the abdominal surgical robots market growth. For instance, on January 8, 2020, US$ 20 million was raised by Virtual Incision Corporation for abdominal robotic surgery.
Market- Trends
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients